Fig. 3
Kaplan–Meyer survival curve. (A) NHFS ≤ 4 vs. > 4- and 30-day mortality; HR 3.94; 95% CI 2.19–7.07; p-value < 0.001). (B) ASA 1–2 vs. 3–4 and 30-day mortality; (HR 2.58; 95% CI 1.43–4.63); p-value = 0.001).
Fig. 3 | Scientific Reports
Kaplan–Meyer survival curve. (A) NHFS ≤ 4 vs. > 4- and 30-day mortality; HR 3.94; 95% CI 2.19–7.07; p-value < 0.001). (B) ASA 1–2 vs. 3–4 and 30-day mortality; (HR 2.58; 95% CI 1.43–4.63); p-value = 0.001).
